Surgery Partners, Inc. (SGRY) Misses Q3 EPS by 6c; reaffirms guidance
Surgery Partners, Inc. (NASDAQ: SGRY) reported Q3 EPS of $0.19, $0.06 worse than the analyst estimate of $0.25. Revenue for the quarter came in at $770.4 million versus the consensus estimate of $768.99 million.
GUIDANCE:
Surgery Partners, Inc. sees FY2024 revenue of $3.075 billion, versus the consensus of $3.086 billion.
For earnings history and earnings-related data on Surgery Partners, Inc. (SGRY) click here.
